cobicistat
SpainDrugs containing this active substance
-
It is used in adults and adolescents aged 12 years or older (weighing at least 35 kg) to help control human immunodeficiency virus (HIV) infection, in combination with other HIV medicines.
Form: tablets, film-coated
Active substance Dosage atazanavir sulfate 341,70 mg cobicistat 294,12 mg Manufacturer: Bristol-Myers Squibb Pharma Eeig
-
It is used for the treatment of human immunodeficiency virus (HIV-1) infection in adults, adolescents, and children aged 6 years or older weighing at least 25 kg. It helps reduce the amount of virus in the body to improve the immune system.
Form: tablets, film-coated
Active substance Dosage emtricitabine 200 mg tenofovir alafenamide 10 mg elvitegravir 150 mg cobicistat 150 mg Manufacturer: Gilead Sciences Ireland Unlimited Company
-
It is used to treat adults and adolescents aged 12 years and older (weighing at least 40 kg) infected with HIV. It helps reduce the amount of HIV in the body and improves the immune system, although it is not a cure.
Form: tablets, film-coated
Active substance Dosage darunavir ethanolate 867,28 mg cobicistat 150 mg Manufacturer: Janssen-Cilag International N.V
-
It is used to treat human immunodeficiency virus (HIV) infection in adults and adolescents aged 12 to 18 years who weigh at least 35 kg and who have previously received other HIV treatments that caused side effects.
Form: tablets, film-coated
Active substance Dosage cobicistat 150 mg emtricitabine 200 mg tenofovir disoproxil fumarate 245 mg elvitegravir 150 mg Manufacturer: Gilead Sciences Ireland Unlimited Company
-
It is used to treat human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents aged 12 years or older who weigh at least 40 kg. It helps reduce the amount of virus in the body and improves the immune system, although it is not a cure.
Form: tablets
Active substance Dosage darunavir ethanolate 867 mg cobicistat 150 mg emtricitabine 200 mg tenofovir alafenamide fumarate 11,2 mg Manufacturer: Janssen-Cilag International N.V
-
It is used for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and adolescents 12 years of age and older. It does not treat the infection directly, but acts as a booster for the medications atazanavir or darunavir to enhance their effect in the blood.
Form: tablets, film-coated
Active substance Dosage cobicistat 288,5 mg Manufacturer: Gilead Sciences Ireland Unlimited Company